Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading CODEXIS, INC. chart...

About the Company

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Exchange

Nasdaq

$13M

Total Revenue

336

Employees

$200M

Market Capitalization

-2.34

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CDXS News

Codexis to Report First Quarter 2024 Financial Results on May 2

4d ago, source:

REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 ...

Codexis (NASDAQ: CDXS)

6d ago, source: The Motley Fool

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

12d ago, source: Business Insider

REDWOOD CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Carole Cobb, MBA, to the Company’s ...

Codexis: Q4 Earnings Snapshot

1mon ago, source: SFGate

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Wednesday reported a loss of $7.2 million in its fourth quarter. The Redwood City, California-based company said ...

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

1mon ago, source: Yahoo Finance

REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ...

Codexis Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect

1mon ago, source: Hosted on MSN

Codexis, Inc CDXS has an Earnings ESP of +81.25% and a Zacks Rank #2 at present. CDXS is scheduled to report fourth-quarter fiscal 2023 earnings on Feb 28. You can see the complete list of today ...

Codexis Inc

1mon ago, source: OpenSecrets.org

*Each quarterly filing is treated as a separate report. Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...